Lv2
180 积分 2025-03-16 加入
生成式人工智能服务管理暂行办法
26天前
已完结
The Efficacy and Safety of Trastuzumab in the Metastatic Breast Cancer
1个月前
已完结
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
6个月前
已完结
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
6个月前
已完结
Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial
9个月前
已完结
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
9个月前
已完结
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
9个月前
已关闭
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors
9个月前
已关闭
CONCURRENT USE OF ABEMACICLIB AND RADIOTHERAPY IN METASTATIC BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE
9个月前
已完结
CONCURRENT USE OF ABEMACICLIB AND RADIOTHERAPY IN METASTATIC BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE
9个月前
已完结
皖公网安备34019202002308
